Related Experiment Video
Updated: Jun 16, 2026

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network
Published on: January 29, 2018
HIV is associated with thrombophilia and high D-dimer in children and adolescents
Giuseppe Pontrelli1, Alessandra M Martino, Hyppolite K Tchidjou
1Department of Public Health,Ospedale Pediatrico Bambino Gesù, Rome, Italy. giuseppe.pontrelli@opbg.net
Insights
High viral replication in HIV-infected youth is linked to blood clotting problems. This suggests that controlling HIV viral load may improve coagulation and reduce cardiovascular risk in children.
Area of Science:
- Pediatric Infectious Diseases
- Hematology
- Cardiovascular Health
Background:
- Combination antiretroviral therapy (cART) has improved survival for HIV-infected individuals, shifting focus to non-AIDS comorbidities like cardiovascular disease.
- Thrombosis and atherosclerosis are increasingly recognized as significant risks in HIV-infected patients, particularly with improved longevity.
Purpose of the Study:
- To investigate the association between viral replication levels and coagulation abnormalities in children and adolescents with HIV.
- To assess the prevalence of thrombophilic markers in this pediatric cohort.
Main Methods:
- A cross-sectional study was conducted on HIV-infected children and adolescents.
- Assayed protein S, protein C, antithrombin activity, fibrinogen, D-dimer, hs-CRP, and homocysteine.
- Compared results between patients with high viral load (HVL) and low viral load (LVL), adjusting for covariates.
Main Results:
- 51% had protein S deficiency and 8% had protein C deficiency.
- The HVL group showed significantly reduced protein S, protein C, and antithrombin activities compared to the LVL group.
- High viral load was independently associated with decreased protein S activity and increased D-dimer levels.
Conclusions:
- HIV-infected children and adolescents exhibit a high prevalence of thrombophilic abnormalities.
- High viral replication is an independent risk factor for decreased protein S and increased D-dimer.
- Suppressive HIV therapy may benefit coagulation homeostasis, highlighting the need for early cardiovascular risk factor management.
Background And Objective:
Atherosclerosis and other cardiovascular diseases associated with thrombosis appear more relevant and anticipated in HIV-infected patients after combination antiretroviral therapy (cART) has reduced AIDS-related diseases and has improved survival. The association between viral replication and coagulation abnormalities in a cohort of HIV-infected children and adolescents was investigated here.
Methods:
Protein S, protein C anticoagulant and antithrombin activity, together with fibrinogen, D-dimer, high-sensitive C-reactive protein and homocysteine were assayed in a cross-sectional study among a cohort of HIV-infected children and adolescents. Results in patients with high viral load (HVL, HIV-RNA > 1000 copies/ml) were compared with those in patients with a lower replication (LVL), adjusting for other demographic, clinical and therapeutic covariates.
Results:
Eighty-eight patients (mean age 13.5 years, CD4 30%, 72% with LVL) were enrolled. A prevalence of protein S and protein C deficiency of 51 and 8% was, respectively, found. HVL group compared to LVL showed a significant reduction of protein S, protein C and antithrombin activities, and an increase of D-dimer levels. The independent association of HVL with decreased protein S activity (-11.2%, P = 0.04) and increased D-dimer levels (+0.13 microg/ml, P = 0.004) was confirmed in the multivariate model.
Conclusions:
HIV-infected children and adolescents present high prevalence of thrombophilic abnormalities. The multivariate model confirmed that high viral replication is independently associated with decrease of protein S and increase of D-dimer, suggesting the advantage of suppressive therapy on coagulation homeostasis and the opportunity of an active control of cardiovascular risk factors starting at a younger age.
Related Concept Videos
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology
